Literature DB >> 9822627

Pig heart fumarase contains two distinct substrate-binding sites differing in affinity.

S Beeckmans1, E Van Driessche.   

Abstract

A eukaryotic fumarase is for the first time unequivocally shown to contain two distinct substrate-binding sites. Pig heart fumarase is a tetrameric enzyme consisting of four identical subunits of 50 kDa each. Besides the true substrates L-malate and fumarate, the active sites (sites A) also bind their analogs D-malate and oxaloacetate, as well as the competitive inhibitor glycine. The additional binding sites (sites B) on the other hand also bind the substrates and their analogs D-malate and oxaloacetate, as well as L-aspartate which is not an inhibitor. Depending on the pH, the affinity of sites B for ligands (Kd being in the millimolar range) is 1-2 orders of magnitude lower than the affinity of sites A (of which Kd is in the micromolar range). However, saturating sites B results in an increase in the overall activity of the enzyme. The benzenetetracarboxyl compound pyromellitic acid displays very special properties. One molecule of this ligand is indeed able to bind into a site A and a site B at the same time. Four molecules of pyromellitic acid were found to bind per molecule fumarase, and the affinity of the enzyme for this ligand is very high (Kd = 0.6 to 2.2 microM, depending on the pH). Experiments with this ligand turned out to be crucial in order to explain the results obtained. An essential tyrosine residue is found to be located in site A, whereas an essential methionine residue resides in or near site B. Upon limited proteolysis, a peptide of about 4 kDa is initially removed, probably at the C-terminal side; this degradation results in inactivation of the enzyme. Small local conformational changes in the enzyme are picked up by circular dichroism measurements in the near-UV region. This spectrum is built up of two tryptophanyl triplets, the first one of which is modified upon saturating the active sites (A), and the second one upon saturating the low affinity binding sites (B).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9822627     DOI: 10.1074/jbc.273.48.31661

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Identification of the catalytic mechanism and estimation of kinetic parameters for fumarase.

Authors:  Muriel Mescam; Kalyan C Vinnakota; Daniel A Beard
Journal:  J Biol Chem       Date:  2011-04-15       Impact factor: 5.157

2.  Selective disruption of protein aggregation by cyclodextrin dimers.

Authors:  D K Leung; Z Yang; R Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

3.  Selective small molecule inhibitor of the Mycobacterium tuberculosis fumarate hydratase reveals an allosteric regulatory site.

Authors:  Monica Kasbekar; Gerhard Fischer; Bryan T Mott; Adam Yasgar; Marko Hyvönen; Helena I M Boshoff; Chris Abell; Clifton E Barry; Craig J Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-20       Impact factor: 11.205

4.  The role of the allosteric B site in the fumarase reaction.

Authors:  Irwin A Rose; Todd M Weaver
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-27       Impact factor: 11.205

5.  In silico prediction of antimalarial drug target candidates.

Authors:  Philipp Ludin; Ben Woodcroft; Stuart A Ralph; Pascal Mäser
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-07-17       Impact factor: 4.077

6.  Novel role of fumarate metabolism in dahl-salt sensitive hypertension.

Authors:  Zhongmin Tian; Yong Liu; Kristie Usa; Domagoj Mladinov; Yi Fang; Xiaoqiang Ding; Andrew S Greene; Allen W Cowley; Mingyu Liang
Journal:  Hypertension       Date:  2009-06-22       Impact factor: 10.190

7.  Identification of a novel fumarase C from Streptomyces lividans TK54 as a good candidate for L-malate production.

Authors:  Rui-Rui Su; Ao Wang; Song-Tao Hou; Peng Gao; Guo-Ping Zhu; Wen Wang
Journal:  Mol Biol Rep       Date:  2013-12-05       Impact factor: 2.316

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.